Geneva, June 22 -- International Clinical Trials Registry received information related to the study (ChiCTR2600126458) titled 'Phase II clinical trial evaluating the use of AHB-137 for the treatment-naive participants with chronic hepatitis B' on June 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The 2nd Affiliated Hospital of Chongqing Medical University
Condition:
Chronic hepatitis B
Intervention:
Control group:A weekly subcutaneous injection of the placebo of AHB-137 injection at a dose of 300mg was administered on days 4 and 11, and the corresponding loadin.
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-06-30
Target Sample Size: Control group:80;Experimental gro...